Literature DB >> 6167031

Serological and biochemical analysis of Ia molecules in the I-A mutant B6.C-H-2.

W P Lafuse, J F McCormick, R W Melvold, C S David.   

Abstract

Strain B6.C-H-2bm12 has a mutation in the I-A subregion of the mouse H-2 gene complex, which causes skin graft rejection, mixed lymphocyte reaction (MLR), and alterations in the expression of Ia antigens. The mutation affects the expression of Ia.3, 8, 9, 15, and 20 on normal spleen cells. When the spleen cells were stimulated with lipopolysaccharide (LPS), the expression of all Ia specificities were found except Ia.8. Ia molecules when internally labeled with 3H-leucine can be precipitated with antisera directed against Ia.3, 9, 15, and 20, but not Ia.8. When F1s are made between the mutant bm12 and unrelated haplotypes, Ia.3, 9, 15 and 20 can be detected by microcytotoxic assay on normal spleen cells, but not Ia.8. These studies suggest: (1) The mutation affects either the amount of Ia molecules expressed on normal spleen cell surfaces or the molecule is anchored improperly in the cell surface such that it is not accessible for cytotoxicity and radioiodination. (2) Specificity Ia.8, which may be a combinatorial determinant, is absent in the mutant because of a structural alteration in one of the chains, probably the beta chain. (3) The mutation does not involve the Ae chain. The significance of this finding in relation to I region-mediated allorecognition and antigen presentation is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167031     DOI: 10.1097/00007890-198106000-00006

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

Review 1.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

Review 2.  T cells, murine chronic graft-versus-host disease and autoimmunity.

Authors:  Robert A Eisenberg; Charles S Via
Journal:  J Autoimmun       Date:  2012-06-16       Impact factor: 7.094

3.  Serological cross-reactivity between products of different Ia loci.

Authors:  P A Lowry; D B Murphy
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Biochemical evidence for multiple I-E Ia molecules.

Authors:  W P Lafuse; P S Corser; C S David
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

5.  Tryptic peptide comparison of Ia antigen alpha and beta polypeptides from the I-A mutant B6.C-H-2bm12 and its congenic parental strain B6.

Authors:  D J McKean; R W Melvold; C David
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Selective loss of antigen-specific Ir gene function in IA mutant B6.C-H-2bm12 is an antigen presenting cell defect.

Authors:  C C Lin; A S Rosenthal; H C Passmore; T H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

7.  Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis.

Authors:  P Christadoss; J M Lindstrom; R W Melvold; N Talal
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

8.  T cell clones specific for hybrid I-A molecules. Discrimination with monoclonal anti-I-Ak antibodies.

Authors:  B N Beck; J G Frelinger; M Shigeta; A J Infante; D Cummings; G Hämmerling; C G Fathman
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

9.  Major histocompatibility complex-restricted antigen presentation to antigen-reactive T cells by B lymphocyte tumor cells.

Authors:  D J McKean; A J Infante; A Nilson; M Kimoto; C G Fathman; E Walker; N Warner
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

10.  Molecular genetic analysis of 178 I-Abm12-reactive T cells.

Authors:  J Bill; J Yagüe; V B Appel; J White; G Horn; H A Erlich; E Palmer
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.